Status:

COMPLETED

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

Lead Sponsor:

Peking Union Medical College Hospital

Conditions:

HIV-infection/AIDS

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

The traditional Chinese herbal medicine Triptolide Wilfordii has displayed remarkable effect on the treatment of autoimmune diseases such as rheumatoid arthritis. Now that immunosuppression therapy ha...

Detailed Description

Acquired immune deficiency syndrome(AIDS) is a severe fatal disease caused by HIV infection. Despite viral suppression achieved, antiretroviral therapy(ART) cannot ameliorate HIV-induced immune activa...

Eligibility Criteria

Inclusion

  • 18\~65 years old;
  • Male or female;
  • Good adherence and promise to follow-up;
  • Inform Consent signed;
  • Positive for HIV antibody test or serum HIV-RNA positive for 2 times or more;

Exclusion

  • Present opportunity infection defined according to national AIDS treatment guideline or active opportunistic infection(not stable within 14 days ) within 3 months before recruitment or AIDS-related carcinoma;
  • Hemoglobin (HGB) \< 9 g/dl, white blood cell (WBC) \< 3000/ul, granulin (GRN) \< 1500 /ul, platelet (PLT) \< 75000 /ul, Cr \>1.5x upper limit of normal (ULN), ALT or AST or alkaline phosphatase (ALP) \>3x ULN, total bilirubin (TBIL) \>2x ULN;
  • Pregnancy or breastfeeding;
  • Woman with pregnancy plan;
  • Severe organ dysfunction;
  • Administration of immunosuppressor, immunomodulator(including thymocin) or systemic cytotoxic drugs within 6 months before recruitment.

Key Trial Info

Start Date :

September 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2021

Estimated Enrollment :

353 Patients enrolled

Trial Details

Trial ID

NCT03403569

Start Date

September 1 2018

End Date

June 30 2021

Last Update

April 8 2022

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Mengchao Hepatobiliary Hospital of Fujian Medical University

Fuzhou, Fujian, China, 350025

2

The Eighth People's Hospital of Guangzhou

Guangzhou, Guangdong, China, 510060

3

The Fourth Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China, 150001

4

The Sixth People's Hospital of Zhengzhou

Zhengzhou, Henan, China, 450015

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection | DecenTrialz